Medications for Nonsmall Cell Lung Carcinoma

28 results

  • abraxane - paclitaxel injection, powder, lyophilized, for suspension

    (Paclitaxel)
    Abraxis Bioscience, Llc
    ABRAXANE treats metastatic breast cancer after prior chemotherapy failure, locally advanced or metastatic non-small cell lung cancer (first-line with carboplatin) in patients ineligible for surgery or radiation, and metastatic pancreatic adenocarcinoma (first-line with gemcitabine).
    Medication Details
    Drug Interactions

  • alecensa - alectinib hydrochloride capsule

    (Alectinib Hydrochloride)
    Genentech, Inc.
    Alecensa treats adults with ALK-positive non-small cell lung cancer (NSCLC): as adjuvant therapy after resection of tumors ≥4 cm or node-positive, and for metastatic ALK-positive NSCLC. ALK-positive status must be confirmed by an FDA-approved test.
    Medication Details
    Drug Interactions

  • alunbrig - brigatinib tablet, film coated

    (Brigatinib)
    Takeda Pharmaceuticals America, Inc.
    Alunbrig treats adult patients with ALK-positive metastatic non-small cell lung cancer (NSCLC) as detected by an FDA-approved test.
    Medication Details
    Drug Interactions

  • augtyro - repotrectinib capsule

    (Repotrectinib)
    E.R. Squibb & Sons, L.L.C.
    Augtyro treats adults with locally advanced or metastatic ROS1-positive non-small cell lung cancer. It also treats adults and patients aged 12+ with locally advanced or metastatic NTRK gene fusion-positive solid tumors that have progressed on prior treatment or have no satisfactory alternative therapy.
    Medication Details
    Drug Interactions

  • avastin - bevacizumab injection, solution

    (Bevacizumab)
    Genentech, Inc.
    Avastin (bevacizumab) is a VEGF inhibitor used with chemotherapy to treat metastatic colorectal cancer, non-squamous non-small cell lung cancer, metastatic renal cell carcinoma, cervical cancer, ovarian/fallopian tube/peritoneal cancer, and hepatocellular carcinoma. Also indicated for recurrent glioblastoma in adults.
    Medication Details
    Drug Interactions

  • braftovi - encorafenib capsule

    (Encorafenib)
    Array Biopharma Inc.
    Braftovi treats unresectable or metastatic melanoma (BRAF V600E/V600K), metastatic colorectal cancer (BRAF V600E), and metastatic non-small cell lung cancer (BRAF V600E) in adults. Used in combination with binimetinib or cetuximab. Requires FDA-authorized BRAF mutation testing.
    Medication Details
    Drug Interactions

  • cyramza - ramucirumab solution

    (Ramucirumab)
    Eli Lilly And Company
    Cyramza (ramucirumab) treats advanced gastric, gastro-esophageal junction, non-small cell lung, colorectal, and hepatocellular cancers in adults, used alone or with chemotherapy after prior treatment failure or as first-line therapy for EGFR-mutant NSCLC.
    Medication Details
    Drug Interactions

  • enhertu - fam - trastuzumab deruxtecan - nxki injection, powder, lyophilized, for solution

    (Fam-Trastuzumab Deruxtecan-Nxki)
    Daiichi Sankyo Inc.
    ENHERTU treats HER2-positive and HER2-low/ultralow unresectable or metastatic breast cancer in adults, HER2-mutant non-small cell lung cancer, HER2-positive locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma, and HER2-positive (IHC 3+) unresectable or metastatic solid tumors with no satisfactory alternatives.
    Medication Details
    Drug Interactions